AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

American Journal of Public Health, Vol. 68, Issue 11 1116-1120, Copyright © 1978 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kenen, R H
Right arrow Articles by Schmidt, R M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenen, R H
Right arrow Articles by Schmidt, R M
Stigmatization of carrier status: social implications of heterozygote genetic screening programs.

R H Kenen and R M Schmidt

Possible latent psychological and social consequences ensuing from genetic screening programs need to be investigated during the planning phase of national genetic screening programs. The relatively few studies which have been performed to determine psychological, social, and economic consequences resulting from a genetic screening program are reviewed. Stigmatization of carrier-status, having major psychosocial implications in heterozygote genetic screening programs, is discussed and related to Erving Goffman's work in the area of stigmatization. Questions are raised regarding the relationship between such variables as religiosity and sex of the individual and acceptance of the status of newly identified carrier of a mutant gene. Severity of the deleterious gene and visibility of the carrier status are two important factors to consider in an estimation of potential stigma. Specific implications are discussed for four genetic diseases: Tay-Sachs, Sickle-Cell Anemia, Huntington's disease and Hemophilia.




This article has been cited by other articles:


Home page
 Human RelationsHome page
L. A. Barclay and K. S. Markel
Discrimination and stigmatization in work organizations: A multiple level framework for research on genetic testing
Human Relations, June 1, 2007; 60(6): 953 - 980.
[Abstract] [PDF]

Home page
 J Law Med EthicsHome page
L. F. Ross
Heterozygote Carrier Testing in High Schools Abroad: What are the Lessons for the U.S.?
J. Law Med. Ethics, December 1, 2006; 34(4): 753 - 764.
[PDF]

Home page
 ScienceHome page
P. Rowley
Genetic screening: marvel or menace?
Science, July 13, 1984; 225(4658): 138 - 144.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Public Health Association